Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy

Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy

Blog Article

Abstract Cancer immunotherapy, which harnesses the power of the immune system, has shown Table immense promise in the fight against malignancies.Messenger RNA (mRNA) stands as a versatile instrument in this context, with its capacity to encode tumor-associated antigens (TAAs), immune cell receptors, cytokines, and antibodies.Nevertheless, the inherent structural instability of mRNA requires the development of effective delivery systems.

Lipid nanoparticles (LNPs) have emerged as significant candidates for mRNA delivery in cancer immunotherapy, providing both protection to the mRNA and enhanced intracellular delivery efficiency.In this review, we offer a comprehensive summary of the recent advancements in LNP-based Lift Shock mRNA delivery systems, with a focus on strategies for optimizing the design and delivery of mRNA-encoded therapeutics in cancer treatment.Furthermore, we delve into the challenges encountered in this field and contemplate future perspectives, aiming to improve the safety and efficacy of LNP-based mRNA cancer immunotherapies.

Graphical Abstract.